A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.
about
Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases.Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenonConnective tissue disease in patients presenting with Raynaud's phenomenon alone.Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls.2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Prevalence of symptoms of Raynaud's phenomenon in general practiceWork disability benefits due to musculoskeletal disorders among Brazilian private sector workersPrevalence of Raynaud's phenomenon in a healthy Greek populationNailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational studyItems for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseEarly systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement.Clinical aspects of systemic sclerosis (scleroderma).The acute blue finger: management and outcomeDiagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus.Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.Epidermal growth factor-mediated effects on equine vascular smooth muscle cells.Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.Abnormal nail fold capillaroscopic findings in patients with coronary slow flow phenomenon.The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.[Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study.Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy.2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Assessing nailfold microvascular structure with ultra-wideband raster-scan optoacoustic mesoscopy.
P2860
Q30812268-C94F4AB7-3B20-4D2F-9FE7-EFF162CA7296Q33311303-C30535C7-8B98-42EF-8019-50ED5405B2A1Q33555611-1B0869F1-9A0D-4696-AF67-7CEE9375F22BQ33563891-A4F036E1-B3C4-4E48-90CC-4732E48ECECAQ33570128-B397CA30-0A9E-4768-836E-A5B266AC98E6Q33579122-5563BC84-4223-41DB-B036-E1D4147F8D45Q34375158-A3AE8380-CC50-4C0D-9615-8DF5C46E9128Q35170461-F4FC9DDA-EC3C-4EEB-A171-9F71E84A534AQ35319785-18E46DD5-1C14-4A7C-8493-0E29C13CDB9FQ35549186-F00E4489-7AB9-4345-8303-67B34EA4CD2AQ35552695-1C5D8CFA-1B76-4CAB-90C8-018657887F3EQ35784089-408804CA-BDC5-41D1-997A-0005882F1072Q36633414-003B356F-A71F-4EA4-9742-BBECFFC85B4BQ36824545-A840D6E0-4EB4-46FE-AA0D-A7B0A25C66C6Q37242967-610B1F21-CF24-42E6-A605-679E3C636D98Q37778648-9D9BF877-8B53-4D29-A377-E72DF8423576Q38922023-2ED106F1-306D-4956-9E3E-6FB492136DA6Q39277981-82D6A1D4-CDFF-4262-95A0-C9DA6EB4A8ABQ39294413-2DECBE03-FF82-4EF1-B348-F791BF6DFF2DQ39304783-C1D6B549-D356-4937-B12E-3673DD309564Q40282917-F245F20B-4DED-4A3D-B796-F28ACC6A1046Q40715243-A91FCD22-A80B-4DAF-8E65-F18A3217BC80Q41214015-992AA953-722D-48AB-AB16-BC37B5F36B26Q43612095-13B4D6D4-C413-4CB7-9864-3FBF467D4AB3Q44727615-ADB12994-6228-49F2-A340-565C79B94FC2Q47296117-A594B93F-E8F8-4BAE-A0F2-997F20F2B93CQ50917914-30BB7034-BFD9-41FB-8BBE-1514B4A2B0D2Q54164380-595D0EE6-3FAE-40F8-B138-A84656EF6767Q55455485-744E0F94-B748-4B3D-AC03-8F69136C5ABE
P2860
A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
A prospective study of Raynaud ...... e disease. A five-year report.
@en
A prospective study of Raynaud ...... e disease. A five-year report.
@nl
type
label
A prospective study of Raynaud ...... e disease. A five-year report.
@en
A prospective study of Raynaud ...... e disease. A five-year report.
@nl
prefLabel
A prospective study of Raynaud ...... e disease. A five-year report.
@en
A prospective study of Raynaud ...... e disease. A five-year report.
@nl
P2093
P1476
A prospective study of Raynaud ...... e disease. A five-year report.
@en
P2093
F E Harper
H R Maricq
R E Turner
R W Lidman
P304
P356
10.1016/0002-9343(82)90846-4
P407
P577
1982-06-01T00:00:00Z